Literature DB >> 1793052

Effects of IL-1 muteins on cartilage degradation and as inducers of acute inflammation.

M A Pratta1, E C Arner, B L Rule, W Galbraith.   

Abstract

IL-1 peptides with N-terminal amino acid mutations were cloned and expressed to help characterize structural requirements for activity. Addition of Thr-Asn to the N-terminus (DP516) or substitution of the first two residues (Ala-Pro) of mature, native IL-1 beta with Thr-Met (DuP118) had no effect on the potency of the muteins in stimulating proteoglycan breakdown and inhibiting proteoglycan synthesis in vitro, or inducing mouse paw swelling in vivo. When Arg in position 4 of DuP118 was replaced by Glu (Glu-4), proteoglycan-synthesis-inhibitory activity was reduced to 20% and proteoglycan-degrading activity to 2% of that induced by native IL-1 beta. Glu-4 was much less active in inducing mouse paw swelling and gave maximal swelling about 40% that of native IL-1 beta. The data suggest that the presence of the positively charged side chain of Arg in position 4 may be important for the activity of IL-1 and may be useful in designing specific IL-1 receptor agonists/antagonists.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1793052     DOI: 10.1007/bf01993238

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  6 in total

1.  Independent effects of interleukin-1 on proteoglycan breakdown, proteoglycan synthesis, and prostaglandin E2 release from cartilage in organ culture.

Authors:  E C Arner; M A Pratta
Journal:  Arthritis Rheum       Date:  1989-03

2.  Interleukin 1: a common endogenous mediator of inflammation and the local Shwartzman reaction.

Authors:  G Beck; G S Habicht; J L Benach; F Miller
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

3.  Isolation of an interleukin-1-like factor from human joint effusions.

Authors:  D D Wood; E J Ihrie; C A Dinarello; P L Cohen
Journal:  Arthritis Rheum       Date:  1983-08

4.  High-level expression in Escherichia coli of a soluble and fully active recombinant interleukin-1 beta.

Authors:  J J Huang; R C Newton; K Pezzella; M Covington; T Tamblyn; S J Rutlege; J Gray; M Kelley; Y Lin
Journal:  Mol Biol Med       Date:  1987-06

5.  Multiple biological activities of human recombinant interleukin 1.

Authors:  C A Dinarello; J G Cannon; J W Mier; H A Bernheim; G LoPreste; D L Lynn; R N Love; A C Webb; P E Auron; R C Reuben
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

6.  Muteins of human interleukin-1 that show enhanced bioactivities.

Authors:  J J Huang; R C Newton; R Horuk; J B Matthew; M Covington; K Pezzella; Y A Lin
Journal:  FEBS Lett       Date:  1987-11-02       Impact factor: 4.124

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.